Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?

https://doi.org/10.1016/j.hoc.2021.03.007Get rights and content
Under a Creative Commons license
open access

Keywords

MRD
Minimal residual disease
CLL
Chronic lymphocytic leukemia
Targeted agents
Chemoimmunotherapy
Fixed-duration therapy

Cited by (0)